Defining heterogeneity of epicardial functional stenosis with low coronary flow reserve by unsupervised machine learning.


Journal

Heart and vessels
ISSN: 1615-2573
Titre abrégé: Heart Vessels
Pays: Japan
ID NLM: 8511258

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 02 04 2020
accepted: 29 05 2020
pubmed: 9 6 2020
medline: 15 12 2020
entrez: 8 6 2020
Statut: ppublish

Résumé

Low CFR is associated with poor prognosis, whereas it is a heterogeneous condition according to the actual coronary flow, such as high resting or low hyperemic coronary flow, which should have different physiological traits and clinical implications. This study aimed to detect and define the sub-phenotypes of vessels with low coronary flow reserve (CFR) epicardial disease by unsupervised machine-learning methods. Hierarchical clustering was applied to 376 vessels from 364 patients with CFR less than the median and fractional flow reserve ≤ 0.8 from a global, multicenter registry. Detailed features of coronary flow physiology and survivals from vessel-oriented composite outcomes (VOCO) were assessed according to the clusters. Clustering defined three distinct physiological subgroups (PS). PS1 (n = 151) were characterized by high resting coronary flow, dominantly left anterior descending artery (LAD) lesions. PS2 (n = 131) were, in contrast, low hyperemic coronary flow, mainly LAD lesions. PS3 (n = 82) mostly consisted of non-LAD lesions with similar flow status to PS1 except for the low hyperemic Pd. Survivals from VOCO were significantly different according to the clusters (p = 0.005) and PS3 had the highest rate of VOCO. In a COX proportional model predicting VOCO, there was a significant interaction between PCI and PSs, suggesting potentially different effects of PCI on outcome between PS1 and PS2. The unsupervised machine-learning approaches provided unique insights into low CFR condition. Among low CFR epicardial lesions, high resting flow with low hyperemic Pd might be related to poor prognosis, and low hyperemic flow in LAD could benefit from elective PCI. CLINICAL TRIAL REGISTRATION INFORMATION: https://clinicaltrials.gov/ct2/show/NCT03690713 , NCT03690713.

Identifiants

pubmed: 32506182
doi: 10.1007/s00380-020-01640-x
pii: 10.1007/s00380-020-01640-x
doi:

Banques de données

ClinicalTrials.gov
['NCT03690713']

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1527-1536

Auteurs

Rikuta Hamaya (R)

Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital, Ibaraki, Japan.
Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Masahiro Hoshino (M)

Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital, Ibaraki, Japan.

Taishi Yonetsu (T)

Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan.

Joo Myung Lee (JM)

Division of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.

Bon-Kwon Koo (BK)

Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, South Korea.
Institute on Aging, Seoul National University, Seoul, South Korea.

Javier Escaned (J)

Cardiovascular Institute, Hospital Clinico San Carlos, Madrid, Spain.
Centro Nacional de Investigaciónes Cardiovasculares Carlos III (CNIC), Madrid, Spain.

Tsunekazu Kakuta (T)

Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital, Ibaraki, Japan. kaz@joy.email.ne.jp.
Department of Cardiology, Tsuchiura Kyodo General Hospital, 4-4-1 Otsuno, Tsuchiura, Ibaraki, 300-0028, Japan. kaz@joy.email.ne.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH